Cornstarch Powders Don’t Pose Risk of Ovarian Cancer - Study
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




Cornstarch Powders Don’t Pose Risk of Ovarian Cancer - Study

WHITE PLAINS, N.Y., March 14, 1997 -- Supporters of cornstarch-based feminine powders are questioning the validity of recent findings which linked the use of such powders with the risk of ovarian cancer.

The study, published in the March edition of the American Journal of Epidemiology and entitled, "Perineal Powder Exposure and the Risk of Ovarian Cancer," was reviewed by the Cosmetics, Toiletries and Fragrance Association (CTFA) in Washington, D.C. with independent experts in epidemiology and states.

"Our review raises fundamental questions regarding the validity of the authors' conclusions," states the CTFA in a press release today.

Additionally, Dr. Renate Kimbrough, formerly with the Center for Disease Control (CDC) and now a member of the Institute for Evaluating Health Risks, says in a statement prepared for CTFA that, "... the paper suffers from methodological shortcomings ... the authors have not demonstrated that perineally applied powder represents a risk for the development of ovarian cancer."

"Vagisil Feminine Powder, a cornstarch-based powder, is safe and does not pose an increased risk of ovarian cancer," says Dr. Stephen Pennisi, Director of Toxicology and Product Safety for Combe Incorporated, makers of Vagisil Powder.

Dr. Pennisi adds, "It is worth pointing out that, in spite of the questions raised about the study, the relative risk of ovarian cancer associated with cornstarch-based powder (0.9) was actually less than for women who had never used any powder (1.0)."

Combe has been manufacturing its Vagisil Feminine Powder, a cornstarch-based product, which contains no talc and was formulated with the aid of a gynecologist, for the past 12 years.

"The safety of cornstarch as a pure food and pharmaceutical ingredient is unquestioned," says Dr. Pennisi. "It is the key reason we developed Vagisil Powder with cornstarch in the first place."

E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities